Hypoglycemia, cardiovascular outcomes, and death
When administered at elevated doses (25 g per kg per day), it activates AMPK and improves metabolic dysfunction in obese mice, including modest effects in weight gain 12,13,14,15
MASH, formerly known as non-alcohol related steatohepatitis (NASH), is characterized by inflammation and damage of the liver caused by the accumulation of fat cells (steatosis) without significant alcohol consumption, which can lead to liver fibrosis (scarring), cirrhosis (severe scarring of the liver) and liver failure
When you are dealing with rare events in clinical trials, even a handful of additional cases can produce alarming-looking relative risk numbers
For researchers managing semaglutide fatigue alongside GI symptoms, the combination can sometimes indicate that the dose escalation is moving too quickly